Action and Impact: Prevention and Screening Strategies Contributing to the Elimination of Cervical Cancer

Dear Colleagues,

Cervical cancer is a preventable public health problem. This is one of the only cancers that has a clear preventable cause, human papillomavirus (HPV). There are several HPV vaccines; they are safe and effective in preventing cervical cancer. We can also screen for cervical cancer using safe, effective and inexpensive methods, e.g., HPV DNA testing.  This is a cancer where we have the tools available to eliminate cervical cancer. Yet, one woman dies every two minutes from this disease worldwide.

For this Special Issue, we are pleased to invite you to submit original research articles and commentaries on the implementation of cervical cancer prevention and/or screening practices that are contributing to the goal of eliminating cervical cancer. We welcome articles that examine the challenges, successes and/or commitment of political, medical and public health officials to make this goal a reality. This includes actionable suggestions or examples, e.g., the implementation of new pilot programs, in individual communities/countries to inspire action globally among scientists, healthcare providers, policy leaders and communities to accelerate progress toward the attainable goal of cervical cancer elimination.

I look forward to receiving your contributions.

Dr. Samara Perez
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• HPV
• cervical cancer
• cancer prevention
• cancer screening